Skip to content

The effect of Guided Imagery on Nausea and Vomiting and Quality of Life in Cancer Chemotherapy

Exploring the effects of Guided Imagery on Gastrointestinal complications and Quality of Life in Cancer patients undergoing Chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200710048073N1
Enrollment
70
Registered
2021-02-27
Start date
2021-02-28
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Chemotherapy-induced Nausea and Vomiting in Cancer. Condition 2: Quality of Life in Cancer patients undergoing Chemotherapy. Neoplasms of unspecified behavior Neoplasms of unspecified behavior

Interventions

Intervention 1: The intervention group will be given a Guided Imagery instruction by the researcher during one hour, then the audio file prepared by the researcher will be provided to the intervention

Sponsors

Bagheiat-allah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age above 18 years and under 65 years Minimum Education Level Willingness to participate in research Nausea and Vomiting experience during the Chemotherapy At least one session of Chemotherapy is performed and at least one course of Chemotherapy has left after enrollment

Exclusion criteria

Exclusion criteria: Use of Nausea and Vomiting Medications other than routine and use of Complementary Medications such as Ginger Gastrointestinal Cancer Performing Radiotherapy simultaneously with Chemotherapy Hearing disorders History of Gastrointestinal Surgery Gastrointestinal Cancer History of mental disorder The participant is a member of the Healthcare team Have taken psychological skills training courses such as relaxation

Design outcomes

Primary

MeasureTime frame
Nausea and Vomiting. Timepoint: Pre-intervention? post-intervention and two months after the intervention. Method of measurement: Nausea and Vomiting Questionnaire (The Multinational Association of Supportive Care in Cancer.;Quality of Life. Timepoint: Pre-intervention and two months after the intervention. Method of measurement: Quality of Life Questionnaire - ( European Organization for Research and Treatment of Cancer).

Secondary

MeasureTime frame
Nausea and Vomiting. Timepoint: Pre-intervention and after Chemotherapy and two months after the intervention. Method of measurement: Questionnaire Antiemesis Tool- The Multinational Association of Supportive Care in Cancer -.;Quality of Life. Timepoint: Pre-intervention and two months after the intervention. Method of measurement: Quality of Life Questionnaire - ( European Organization for Research and Treatment of Cancer).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhamseh Feryal

Bagheiat-allah University of Medical Sciences

khamseh_110@yahoo.com+98 21 8755 5491

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026